{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-216632","form_type":"8-K","ticker":"STOK","cik":"0001623526","company_name":"Stoke Therapeutics, Inc.","filed_at":"2024-09-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.845384+00:00","generated_at":"2026-05-31T05:39:21.121628+00:00","sec_items":["8.01","9.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Stoke Therapeutics settles shareholder derivative lawsuit; $590K in fees, governance reforms","bullets":["Mootness fee of $175,000 paid to resolve certain director compensation claims; company denies wrongdoing.","Proposed settlement filed Aug 20, 2024; includes corporate governance reforms and up to $415,000 in attorney fees.","Reforms cap director compensation at 65th percentile of peer group and require value-based equity grants and annual consultant review.","Court approval required; settlement hearing scheduled for Oct 28, 2024.","Company agrees to maintain reforms for five years."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-216632","json":"https://secwatch.observer/filing/0001193125-24-216632.json","markdown":"https://secwatch.observer/filing/0001193125-24-216632.md","text":"https://secwatch.observer/filing/0001193125-24-216632.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1623526/000119312524216632/0001193125-24-216632-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1623526/000119312524216632/d836605d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:39:21.121628+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}